Table 4.
Correlation of oxidative balance score with colorectal cancer complications.
| Complications | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Secondary Metastasis in CRC | 1.043(1.000~1.089) | 0.050 | 1.050(1.002~1.100) | 0.041 | 1.052(1.004~1.102) | 0.035 |
| Secondary Metastasis in Proximal CRC | 0.975(0.948~1.003) | 0.079 | 0.967(0.938~0.996) | 0.025 | 0.967(0.938~0.996) | 0.025 |
| Abdominal pain in Proximal CRC | 0.962(0.932~0.994) | 0.019 | 0.955(0.922~0.988) | 0.008 | 0.954(0.922~0.988) | 0.008 |
| Abdominal pain in distal CRC | 1.043(1.000~1.089) | 0.050 | 1.050(1.002~1.100) | 0.041 | 1.052(1.004~1.102) | 0.035 |
Model 1 was adjusted for age, race, educational attainment, and Townsend deprivation index. Model 2, building upon Model 1, adjusted for dietary energy intake; Model 3: In addition to Model 2, adjusted for plasma CRP concentration and NSAIDs medication usage. CRC, Colorectal Cancer; HR, Hazard Ratio; CI, Confidence Interval.